Aalbers S, Fusar-Poli L, Freeman RE, Spreen M, Ket JC, Vink AC, Maratos A, Crawford M, Chen XJ, Gold C (2017) Music therapy for depression. Cochrane Database Syst Rev 11:CD004517

PubMed  Google Scholar 

Ahmed RM, Bocchetta M, Todd EG, Tse NY, Devenney EM, Tu S, Caga J, Hodges JR, Halliday GM, Irish M, Kiernan MC, Piguet O, Rohrer JD (2021) Tackling clinical heterogeneity across the amyotrophic lateral sclerosis-frontotemporal dementia spectrum using a transdiagnostic approach. Brain Commun 3:257

Article  Google Scholar 

Alqallaf A, Cates DW, Render KP, Patel KA (2023) Sodium phenylbutyrate and taurursodiol: a new therapeutic option for the treatment of amyotrophic lateral sclerosis. Ann Pharmacother: 10600280231172802

American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders 5th Ed. (DSM–5). Arlington, VA: American Psychiatric Publishing

Atassi N, Cook A, Pineda CM, Yerramilli-Rao P, Pulley D, Cudkowicz M (2011) Depression in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 12:109–112

Article  PubMed  Google Scholar 

Bede P, Omer T, Finegan E, Chipika RH, Iyer PM, Doherty MA, Vajda A, Pender N, McLaughlin RL, Hutchinson S, Hardiman O (2018) Connectivity-based characterisation of subcortical grey matter pathology in frontotemporal dementia and ALS: a multimodal neuroimaging study. Brain Imaging Behav 12:1696–1707

Article  PubMed  Google Scholar 

Beeldman E, Raaphorst J, Klein Twennaar M, de Visser M, Schmand BA, de Haan RJ (2016) The cognitive profile of ALS: a systematic review and meta-analysis update. J Neurol Neurosurg Psychiatry 87:611–619

Article  PubMed  Google Scholar 

Benbrika S, Doidy F, Carluer L, Mondou A, Pélerin A, Eustache F, Viader F, Desgranges B (2021) Longitudinal study of cognitive and emotional alterations in amyotrophic lateral sclerosis: clinical and imaging data. Front Neurol 12:620198

Article  PubMed  PubMed Central  Google Scholar 

Berry JD, Blanchard M, Bonar K, Drane E, Murton M, Ploug U, Ricchetti-Masterson K, Savic N, Worthington E, Heiman-Patterson T (2023) Epidemiology and economic burden of amyotrophic lateral sclerosis in the United States: a literature review. Amyotroph Lateral Scler Frontotemporal Degener 24:436–448

Article  PubMed  Google Scholar 

Beswick E, Park E, Wong C, Mehta AR, Dakin R, Chandran S, Newton J, Carson A, Abrahams S, Pal S (2021) A systematic review of neuropsychiatric and cognitive assessments used in clinical trials for amyotrophic lateral sclerosis. J Neurol 268:4510–4521

Article  PubMed  Google Scholar 

Bireley JD, Morren JA (2023) CNM-Au8: an experimental agent for the treatment of amyotrophic lateral sclerosis (ALS). Expert Opin Investig Drugs 32:677–683

Article  CAS  PubMed  Google Scholar 

Borgheai SB, McLinden J, Mankodiya K, Shahriari Y (2020) Frontal functional network disruption associated with amyotrophic lateral sclerosis: an fNIRS-based minimum spanning tree analysis. Front Neurosci 14:613990

Article  PubMed  PubMed Central  Google Scholar 

Brooks BR, Miller RG, Swash M, Munsat TL (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293–299

Article  CAS  PubMed  Google Scholar 

Bungener C (2012) Emotions and amyotrophic lateral sclerosis: a psychopathological perspective. Geriatr Psychol Neuropsychiatr Vieil 10:57–64

PubMed  Google Scholar 

Bungener C, Piquard A, Pradat PF, Salachas F, Meininger V, Lacomblez L (2005) Psychopathology in amyotrophic lateral sclerosis: a preliminary study with 27 ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord 6:221–225

Article  PubMed  Google Scholar 

Butylin DY, Krylov VI, Chesnokova OI, Mikheeva VA (2022) Clinical features of mental disorders in amyotrophic lateral sclerosis. Zh Nevrol Psikhiatr Im S S Korsakova 122:59–64

Article  CAS  PubMed  Google Scholar 

Caga J, Ramsey E, Hogden A, Mioshi E, Kiernan MC (2015) A longer diagnostic interval is a risk for depression in amyotrophic lateral sclerosis. Palliat Support Care 13:1019–1024

Article  PubMed  Google Scholar 

Carvalho MD, Swash M (2009) Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis. Amyotroph Lateral Scler 10:53–57

Article  PubMed  Google Scholar 

Castelnovo V, Canu E, Calderaro D, Riva N, Poletti B, Basaia S, Solca F, Silani V, Filippi M, Agosta F (2020) Progression of brain functional connectivity and frontal cognitive dysfunction in ALS. Neuroimage Clin 28:102509

Article  PubMed  PubMed Central  Google Scholar 

Chen D, Guo X, Zheng Z, Wei Q, Song W, Cao B, Huang R, Yang R, Shang H (2015) Depression and anxiety in amyotrophic lateral sclerosis: correlations between the distress of patients and caregivers. Muscle Nerve 51:353–357

Article  PubMed  Google Scholar 

Christidi F, Karavasilis E, Riederer F, Zalonis I, Ferentinos P, Velonakis G, Xirou S, Rentzos M, Argiropoulos G, Zouvelou V, Zambelis T, Athanasakos A, Toulas P, Vadikolias K, Efstathopoulos E, Kollias S, Karandreas N, Kelekis N, Evdokimidis I (2018) Gray matter and white matter changes in non-demented amyotrophic lateral sclerosis patients with or without cognitive impairment: a combined voxel-based morphometry and tract-based spatial statistics whole-brain analysis. Brain Imaging Behav 12:547–563

Article  PubMed  Google Scholar 

Ciecwierska K, Lulé D, Bielecki M, Helczyk O, Maksymowicz-Sliwinska A, Finsel J, Nieporecki K, Andersen PM, Ludolph AC, Kuzma-Kozakiewicz M (2023) Quality of life and depression in patients with amyotrophic lateral sclerosis - does the country of origin matter? BMC Palliat Care 22:72

Article  PubMed  PubMed Central  Google Scholar 

Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 391:1357–1366

Article  CAS  PubMed  PubMed Central  Google Scholar 

Colombo E, Poletti B, Maranzano A, Peverelli S, Solca F, Colombrita C, Torre S, Tiloca C, Verde F, Bonetti R, Carelli L, Morelli C, Ratti A, Silani V, Ticozzi N (2023) Motor, cognitive and behavioural profiles of C9orf72 expansion-related amyotrophic lateral sclerosis. J Neurol 270:898–908

Article  CAS  PubMed  Google Scholar 

Costello H, Roiser JP, Howard R (2023) Antidepressant medications in dementia: evidence and potential mechanisms of treatment-resistance. Psychol Med 53:654–667

Article  PubMed  PubMed Central  Google Scholar 

Cragg JJ, Seals R, Cashman N, Weisskopf MG (2016) Journal Club: Depression before and after diagnosis with amyotrophic lateral sclerosis. Neurology 87:e257–e259

Article  PubMed  PubMed Central  Google Scholar 

Cui F, Zhu W, Zhou Z, Ren Y, Li Y, Li M, Huo Y, Huang X (2015) Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease. Neuropsychiatr Dis Treat 11:2847–2854

PubMed  PubMed Central  Google Scholar 

Cui C, Sun J, McKay KA, Ingre C, Fang F (2022) Medication use and risk of amyotrophic lateral sclerosis-a systematic review. BMC Med 20:251

Article  PubMed  PubMed Central  Google Scholar 

Cykowski MD, Powell SZ, Peterson LE, Appel JW, Rivera AL, Takei H, Chang E, Appel SH (2017) Clinical significance of TDP-43 neuropathology in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 76:402–413

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Marchi F, Sarnelli MF, Solara V, Bersano E, Cantello R, Mazzini L (2019) Depression and risk of cognitive dysfunctions in amyotrophic lateral sclerosis. Acta Neurol Scand 139:438–445

Article  PubMed  Google Scholar 

Díaz JL, Sancho J, Barreto P, Bañuls P, Renovell M, Servera E (2016) Effect of a short-term psychological intervention on the anxiety and depression of amyotrophic lateral sclerosis patients. J Health Psychol 21:1426–1435

Article  PubMed  Google Scholar 

Edge R, Mills R, Tennant A, Diggle PJ, Young CA (2020) Do pain, anxiety and depression influence quality of life for people with amyotrophic lateral sclerosis/motor neuron disease? A national study reconciling previous conflicting literature. J Neurol 267:607–615

Article  PubMed  Google Scholar 

Ferentinos P, Paparrigopoulos T, Rentzos M, Zouvelou V, Alexakis T, Evdokimidis I (2011) Prevalence of major depression in ALS: comparison of a semi-structured interview and four self-report measures. Amyotroph Lateral Scler 12:297–302

Article  PubMed  Google Scholar 

Gao M, Zhu L, Chang J, Cao T, Song L, Wen C, Chen Y, Zhuo Y, Chen F (2023) Safety and efficacy of edaravone in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis. Clin Drug Investig 43:1–11

Article  PubMed  Google Scholar 

Geduldig ET, Kellner CH (2016) Electroconvulsive therapy in the elderly: new findings in geriatric depression. Curr Psychiatry Rep 18:40

Article  PubMed  Google Scholar 

Gnanapragasam S, Hopkins CW, Moulton CD (2016) Can pharmacotherapy improve depressive symptoms in patients with amyotrophic lateral sclerosis? A systematic review of the literature. Amyotroph Lateral Scler Frontotemporal Degener 17:289–291

Article  PubMed  Google Scholar 

Gould RL, Coulson MC, Brown RG, Goldstein LH, Al-Chalabi A, Howard RJ (2015) Psychotherapy and pharmacotherapy interventions to reduce distress or improve well-being in people with amyotrophic lateral sclerosis: A systematic review. Amyotroph Lateral Scler Frontotemporal Degener 16:293–302

Article  PubMed  Google Scholar 

Grabler MR, Weyen U, Juckel G, Tegenthoff M, Mavrogiorgou-Juckel P (2018) Death anxiety and depression in amyotrophic lateral sclerosis patients and their primary caregivers. Front Neurol 9:1035

Article  PubMed  PubMed Central  Google Scholar 

Grehl T, Rupp M, Budde P, Tegenthoff M, Fangerau H (2011) Depression and QOL in patients with ALS: how do self-ratings and ratings by relatives differ? Qual Life Res 20:569–574